Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries
Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries: A Randomized Trial
Kafrelsheikh University
80 participants
Feb 5, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to compare the analgesic efficacy and functional outcomes of blocking the nerve to the vastus lateralis (NVL) muscle versus the lateral femoral cutaneous nerve (LFCN).
Eligibility
Inclusion Criteria4
- Age ≥ 18 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) physical status from I to III.
- Underwent knee surgeries under spinal anesthesia.
Exclusion Criteria9
- Pregnancy.
- Coagulopathy.
- Neuromuscular disorders.
- Hematological disorders.
- Mental disorders.
- History of multiple traumas or anesthesia drug allergies.
- Local skin infection at the block site.
- Body mass index (BMI) greater than 40.
- Opioid analgesics or abusing opioids.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients received vastus lateralis nerve block with 5 ml of bupivacaine 0.5%.
Patients received lateral femoral cutaneous nerve block with 5 ml of bupivacaine 0.5%.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06809842